跳至主要内容
临床试验/EUCTR2008-001865-28-GB
EUCTR2008-001865-28-GB进行中(未招募)1 期

The Relationship between Osteoporosis and Aortic Calcification in Postmenopausal Women - Osteoporosis and Aortic Calcification

King's College London0 个研究点目标入组 26 人开始时间: 2008年4月4日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Ambulatory postmenopausal women.
  • Aged 50 years and over.
  • Lumbar spine, femoral neck or total hip bone mineral density measurement more than 2 standard deviations below the young adult mean for healthy women (T-score < -2).
  • Normal or clinically insignificant laboratory values.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Current or recent (within 1 year of enrolment) metabolic bone disorders other than postmenopausal osteoporosis including Paget's disease, renal osteodystrophy, osteomalacia or any other disease known to influence bone metabolism.
  • Treatment with oestrogens, progestins or selective estrogen receptor modulators (SERMS) for longer than 3 months in the past or within 3 months of study enrolement.
  • Previous or current use of oral or intravenous bisphosphonates.
  • Current treatment with corticosteroids, calcitonins, strontium ranelate, anticonvulsants, vitamin D >50,000IU/week, teripatide, PTH 1-84 or any other treatment known to influence bone metabolism.
  • Current use of lipid lowering agents.
  • Abnormalities of the oesophagus and other factors which delay oesophageal emptying such as stricture or achalasia
  • Hypersensitivity to alendronic acid or to any of the excipients
  • Hypocalcaemia

研究者

相似试验